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Sinvestigated on a large scale. The level of neopterin elevated in patients with advanced
systolic heart failure compared with control subjects. The present study assessed the
relationship between neopterin, a novel marker of monocyte activation, and risk of
hospitalization for HF and mortality.
Methods: The examined group was composed of 54 patients with NYHA class III and
IV advanced heart failure and 44 healthy volunteers. All patients medical history was
taken. Physical examination and echocardiographic examinations were performed.
Neopterin concentration in blood serum was determined with a radioimmunological
assay. Twelve months after the patients had left the hospital, their hospital adminis-
tration, clinical symptoms of heart failure and mortality were evaluated.
Results: The mean neopterin levels were signiﬁcantly higher with heart failure
patients compared with control group. The concentration of neopterin was statistically
higher at twenty nine (53,7%) patient whom administer to hospital with decompased
heart failure attacks during follow up (p¼0.028). Concentration of neopterin in patient
with class IV NYHA of heart failure was signiﬁcantly higher than in group of patient
with class III (p>0,001). The neopterin levels were statistically higher at patients who
died (35,1%), (p>0,01). On multiple regression analysis, neopterin levels (p¼0.02),
ejection fraction (p>0.001), and hospital administration (p>0.001) were independent
predictors of adverse events.
Conclusions: Serum neopterin is an independent predictor of morbidity in patients
with advanced heart failure. This marker of macrophage activation may be useful
determination prognosis in patients with advanced heart failure patients.Echocardiography
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Aim: The purpose of this study is to determine the long-term prognostic implications
of incidental pleural effusion (PE) detected during echocardiographic examination and
its relationship with concomitant diseases.
Methods: The study was performed by evaluating patient (n¼251) records in whom
PE was incidentally detected during echocardiographic examination in a tertiary
hospital between 1999-2012. The patients were classiﬁed according to the concomi-
tant primary diseases into four major groups; cardiovascular diseases, malignity, renal
dysfunction and pulmonary diseases. The total lifetime is obtained from hospital
records for patients died at hospital and social security institution records for patients
having out-of-hospital death.
Results: Prognostic data of PE according to concomitant illness are as follows:
For those PE concomitant with heart failure (n¼151) patients life expectancies for
one-year was 81% and ﬁve-year was 70%. For patients with malignancies (n¼45)
life expectancies for one-year was 53% and ﬁve-year was 44%. For patients with
pulmonary diseases (n¼37) life expectancies for one-year was 89% and ﬁve-year
was 78%. For patients with renal diseases (n¼18) life expectancies for one-year was
100% and ﬁve-year was 83%. Except PE associated with malignancies others PE
concomitant with heart failure, renal disease, and pulmonary disease have similar
(p>0.05 for all) and favorable outcome than PE concomitant with malignancies
(p<0.001).
Conclusion: The prognosis of incidental diagnosis of PE by echocardiography is the
worst for concomitant with malignancies, however, PE associated with non-malignant
diseases including heart failure, pulmonary and renal diseases have similar and
favorable outcome.C80 JACC VEpidemiology
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The aim of the study: Identiﬁcation and assessment of the risk of diabetes in patients
with different risk of cardiovascular complications in cardiology practice.
Materials and methods: The study included 300 men aged 40 to 69 years with low-
to-moderate (<5% on the scale of SCORE, n¼100), high (5-10% on a scale of SCORE,
n¼101) and very high (>10% on the scale of SCORE, n¼99), cardiovascular risk
without clinical manifestations of CVD and diabetes. Questioning the patients was
conducted byRussian version of a standard questionnaireARIC (Atherosclerosis Risk in
Communities). Predicted risk of developing T2DM in the next 10 years was determined
by questionnaire FINDRISC. All patients underwent tool (BPmeasurement, calculation
BMI, waist circumference) and laboratory (lipids, C reactive protein, uric acid, immu-
noreactive insulin, fasting glucose and 2 hours after taking 75 g of glucose) study.
Results: In the studied cohort of men with different levels of cardiovascular risk by
SCORE scale in 28% of cases, revealed a low risk of developing T2DM, with 32.3%
of those found moderately-high risk, whereas about 40% of men at the time of
examination of a very high risk of developing T2DM. Among men with high and very
high risk of developing T2DM in 53.8% of cases are of a very high cardiovascular
risk. The men in the low-to-moderate cardiovascular risk pre-diabetes is detected in
21% of cases in individuals at high cardiovascular risk in 40% of cases, while 62% of
men with very high cardiovascular risk is diagnosed early disorders of carbohydrate
metabolism. Predicted risk of diabetes has the highest correlation with the level of
fasting and after load blood glucose, immunoreactive insulin, with the cardiovascular
risk by SCORE, BP, total cholesterol, LDL cholesterol and triglycerides. Mild but
signiﬁcant correlation was found between the risk of developing diabetes and uric
acid, C-reactive protein, HDL cholesterol, left ventricular hypertrophy.
Conclusion: Thus, the application of the scale FINDRISK signiﬁcantly expands the
capabilities of primary care physicians to identify at-risk of developing diabetes. In the
future, conducting advanced diagnostics in the form of glucose tolerance test to
determine the tactics of prevention and medical correction to slow down and prevent
diabetes in men with high and high cardiovascular risk.
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Background: Carotid intima-media thickness (CIMT) is a potential indicator of
subclinical atherosclerosis in patients with psoriasis. Epicardial fat thickness (EFT) is
proposed as a new cardiometabolic risk factor. We evaluated the association between
EFT and CIMT in patients with psoriasis.
Methods: The present study was cross-sectional and observational, 65 patients with
psoriasis and 50 age- and sex- matched control subjects were included the study. Data
about echocardiographic EFT, CIMT, anthropometric measurements, and metabolic
proﬁle were obtained.
Results: The EFT and CIMT were signiﬁcantly increased (7.30.5 mm vs. 6.50.5
mm; p<0.01; 0.740.11 mm vs. 0.600.07 mm; p<0.01, respectively) in patients
with psoriasis compared with the controls. EFT signiﬁcantly correlated with CIMT
(r¼0.66, p<0.001). In a multiple linear regression model in which EFT was inde-
pendently associated with age (b¼0.37, p<0.01), CIMT (b¼0.49, p<0.01), body
mass index (b¼0.33, p¼0.01), high-sensitive C reactive protein (b¼0.39, p¼0.011),
duration of disease (b¼0.35, p¼0.03).
Conclusion: We have demonstrated increased EFT and CIMT in psoriasis patients,
and echocardiographic EFT closely correlated with CIMT in patients with psoriasis.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
